In the latest study of Alzheimer’s disease, the small oligomers formed by Amyloid-β (Aβ) peptide were supposed to be the main toxic species for the neurone. Our lab kept focusing on the structural study of a stable 150-kDa Aβ(1-42) oligomer. Previously, we found two β-strand regions on the Aβ(1-42) sequence, the C-strand (A30 – A42) and the N-strand (E11 – V24), and the C-strands
In the latest study of Alzheimer’s disease, the small oligomers formed by Amyloid-β (Aβ) peptide were supposed to be the main toxic species for the neurone. Our lab kept focusing on the structural study of a stable 150-kDa Aβ(1-42) oligomer. Previously, we found two β-strand regions on the Aβ(1-42) sequence, the C-strand (A30 – A42) and the N-strand (E11 – V24), and the C-strands
We present solid-state NMR measurements of β-strand secondary structure and inter-strand organization within a 150 kDa oligomeric aggregate of the 42-residue variant of the Alzheimer’s amyloid-β peptide (Aβ(1-42)). This oligomer is characterized by a structure that cannot be explained by any previously proposed model for aggregated Aβ. We build upon our previous report of a β-strand spanned by residues 30-42, which arranges into an antiparallel β-sheet. New results presented here indicate that there is a second β-strand formed by residues 11-24. We show negative results for NMR experiments designed to reveal antiparallel β-sheets formed by this β-strand. Remarkably, we show that this strand is organized into a parallel β-sheet despite the co-existence of an antiparallel β-sheet in the same structure. In addition, the in-register parallel β-sheet commonly observed for amyloid fibril structure does not apply to residues 11-24 in the 150 kDa oligomer. Rather, we present evidence for an inter-strand registry shift of 3 residues that alternates in direction between adjacent molecules along the β-sheet. We corroborated this unexpected scheme for β-strand organization using multiple 2-dimensional NMR and 13 C- 13 C dipolar recoupling experiments. Our findings indicate a previously unknown assembly pathway and inspire a suggestion as to why this aggregate does not grow to larger sizes.
In the latest study of Alzheimer’s disease, the small oligomers formed by Amyloid-β (Aβ) peptide were supposed to be the main toxic species for the neurone. Our lab kept focusing on the structural study of a stable 150-kDa Aβ(1-42) oligomer. Previously, we found two β-strand regions on the Aβ(1-42) sequence, the C-strand (A30 – A42) and the N-strand (E11 – V24), and the C-strands
In the latest study of Alzheimer’s disease, the small oligomers formed by Amyloid-β (Aβ) peptide were supposed to be the main toxic species for the neurone. Our lab kept focusing on the structural study of a stable 150-kDa Aβ(1-42) oligomer. Previously, we found two β-strand regions on the Aβ(1-42) sequence, the C-strand (A30 – A42) and the N-strand (E11 – V24), and the C-strands